Taipei, Taiwan

Bo-Sian Lin


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Bo-Sian Lin: Pioneering Target Radiopharmaceuticals in Cancer Treatment

Introduction

Bo-Sian Lin is an innovative inventor based in Taipei, Taiwan. He has made significant strides in the realm of cancer treatment through his work in radiopharmaceuticals. With a focus on enhancing therapeutic applications, Lin’s contributions aim to address critical health challenges posed by various types of cancer.

Latest Patents

Bo-Sian Lin holds one notable patent titled "Kit for Preparation of Target Radiopharmaceuticals and Method of Using It." This invention is centered around a specialized kit designed for the preparation of target radiopharmaceuticals. The method allows for the effective use of these radiopharmaceuticals, which are designed to inhibit tumor growth and metastatic progression in patients suffering from head and neck cancer, lung cancer, and brain cancer. The innovative approach emphasizes the significance of radio-nuclear loading on liposomes, enhancing the delivery and impact of treatment options for affected individuals.

Career Highlights

Bo-Sian Lin is associated with the Institute of Nuclear Energy Research under the Atomic Energy Council, Executive Yuan. His role at this esteemed research institution allows him to collaborate on some of the most cutting-edge projects within the field of nuclear energy and medical applications. Lin’s dedication to cancer research and therapeutic advancements has established him as a prominent figure in his field.

Collaborations

Throughout his career, Lin has worked alongside talented colleagues such as Shu-Pei Chiu and Liang-Ting Lin. These collaborations have bolstered his innovative pursuits and allowed for the cross-pollination of ideas, ultimately enhancing the research outcomes related to radiopharmaceuticals.

Conclusion

In summary, Bo-Sian Lin’s inventive contributions to the preparation and application of target radiopharmaceuticals mark a significant step forward in cancer treatment methodologies. His commitment to research at the Institute of Nuclear Energy Research illustrates the impact that dedicated inventors can have on improving healthcare outcomes and advancing scientific knowledge. As new developments continue to unfold in cancer treatment, Lin's work stands as a beacon of innovation and hope.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…